首页  | 新闻播报

每日新闻播报(November 10)

chinadaily.com.cn 2020-11-10 16:57

A computer image created by Nexu Science Communication together with Trinity College in Dublin, shows a model structurally representative of a betacoronavirus which is the type of virus linked to COVID-19 shared with Reuters on Feb 18, 2020. [Photo/Agencies]

>COVID antigen tests approved
China's top drug regulator has approved two antigen tests for COVID-19 that can produce results within 20 minutes, aimed at expediting management of suspected cases of the virus and boosting testing capacity.
Antigen tests, which detect proteins on the surface of the virus, are considered cheaper and faster, but less accurate than the widely used nucleic acid tests, which look for genetic traces of the virus in samples.
The newly approved tests, developed by Guangzhou Wondfo Biotech Co and Beijing Jinwofu Bioengineering Technology Co, are the first antigen tests for COVID-19 to be approved by the National Medical Products Administration, it said in a statement released on Thursday.
The administration noted, however, that antigen tests alone cannot be used to confirm COVID-19 infection. "Antigen test results should be evaluated along with nucleic acid test results, CT imaging and epidemiologic history before making a diagnosis," it said.


>Stent prices to fall 90%
Centralized procurement of coronary stents is expected to see prices in China fall by at least 90%.
The bulk-buy program is expected to make coronary stents, once priced at more than 10,000 yuan each, available to patients in Chinese hospitals for roughly 1,000 yuan for the treatment of coronary heart disease. It is estimated that the price reduction will save patients some 10.9 billion yuan a year in related expenses.
China has more than 330 million patients with heart disease, according to a report last year by the National Center for Cardiovascular Diseases.
It said the number of patients receiving percutaneous coronary intervention - which uses stents to open narrowed arteries that supply heart muscle with blood - soared dramatically, from 230,000 in 2009 to more than 1 million last year.


Democratic presidential candidate Joe Biden and his wife, Jill, celebrate onstage at a rally in Wilmington, Delaware, on Saturday, after news media announced that he had won the US presidential election. [Photo/Agencies]

>Biden declares victory
US Democratic nominee Joe Biden declared victory in the 2020 presidential race on Saturday night, while US President Donald Trump refused to concede defeat. In a speech delivered from Wilmington, Delaware, Biden urged unity and reached out directly to Trump's supporters.
"Let's give each other a chance," he said, urging Democrats and Republicans to "stop treating our opponents as our enemy."
Earlier in the day, Trump said that the 2020 election is "far from over," vowing to take legal actions.
Biden's speech came a few hours after he had been projected by multiple US media outlets to have won over 270 electoral votes.
Biden has made the ongoing COVID-19 pandemic a central issue of his presidential bid.
Biden said Saturday night that he will name a group of scientists and experts as "transition advisors" to convert his plan to respond to the pandemic into an action blueprint.


>First in line to the throne
Japanese Emperor Naruhito's younger brother, Crown Prince Fumihito, was formally sworn in as first in line to the Chrysanthemum Throne in a traditional palace ritual on Sunday that has been postponed for seven months and scaled down due to the coronavirus pandemic.
The ceremony for the 54-year-old crown prince, better known as Prince Akishino, concludes a series of imperial succession rituals that began in May last year when Naruhito ascended to the throne after their 86-year-old father Akihito abdicated.

Find more audio news on the China Daily app.